⌕
Merck · MRK · NYSE
Tenet 40 · Weak
Compare
$147.76+0.55%At closeTenet 40 · Weak
$147.76+0.81 (+0.55%)
At close: Nov 13, 2026, 4:00 PM ET· NYSE · USD
$149.67+1.91 (+1.29%)
Pre-market: Nov 16, 2026, 8:10 AM ET· last 1-minute bar

Merck (MRK) Stock

Merck (MRK) closed at $147.76 on Nov 13, 2026; its Tenet Score is 40 of 100 against 297 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

1 figure withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$147.76
Nov 13, 2026
Market cap
$364.3B
share price × the latest quarter's diluted weighted-average share count (vendor)
P/E
148.5×
price ÷ earnings
Dividend yield
2.30%
past year's regular dividends ÷ price
52-week range
90.90 – 156.92
low → high · as of close, Nov 13, 2026
Tenet Score
40/100
Weak · 297 Healthcare peers

Industry: Drugs

Merck & Co Inc scores 40/100. Weak. Strongest on growth, financial health is the soft spot, trading at 148× earnings versus 297 Healthcare peers.

Tenet Score · vs sector

n=297
40/ 100
Weak
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
23
Quality
57
Health
14
Growth
67

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueFQualityCHealthFGrowthCMomentumB
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/B
8.1×
price to book value
P/S
5.4×
price to fiscal 2025 sales
ROE
5%
return on equity
Operating margin
32.6%
fiscal 2025, before interest and tax
Net margin
3.6%
of revenue kept
Current ratio
1.35
current assets to liabilities
Net debt / EBITDA
3.4×
leverage, net of cash
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.

The whole report, at a glance · every card is a live peek, click any to open the section

About Merck & Co Inc

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunolog…

Composite computed Nov 13, 2026 · peer basis: Healthcare (n=297) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 506 US ETFs · top wrappers by weightSee all ETFs holding MRK →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

CompanyTenet ScoreMarket cap
Johnson & JohnsonJNJ48$687.9B
Abbvie IncABBV42$521.5B
Novartis AGNVS55$306.3B
AMGEN Inc.AMGN47$251.9B
Gilead Sciences, Inc.GILD37$208.5B
Novo NordiskNVO62$185.9B
Pfizer Inc.PFE50$164.7B
Vertex Pharmaceuticals, Inc.VRTX55$136.6B
Bristol-Myers Squibb Co.BMY51$129.7B
GSK PlcGSK51$108.9B

Compare Merck with

What sector and industry is Merck in?

Merck is in the Healthcare sector and the Drugs industry.

What is Merck's Tenet Score?

Merck's Tenet Score is 40 out of 100, ranked against 297 Healthcare peers as of Nov 13, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.